Gellen B, Thorin-Trescases N, Thorin E, Gand E, et al. Serum tenascin-C is independently associated with increased major adverse
cardiovascular events and death in individuals with type 2 diabetes: a French
prospective cohort. Diabetologia 2020 Feb 10. pii: 10.1007/s00125-020-05108.
PMID: 32040670